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Abstract
Purpose—Dysmobility syndrome was recently proposed as an approach to evaluate the 
musculoskeletal health of older persons, but data linking this syndrome to adverse outcomes are 
currently lacking. The present study used data from the National Health and Nutrition 
Examination Survey (NHANES)1999–2002 to assess the relationship between dysmobility and 
mortality in adults age 50 and older by age, sex, and race or ethnicity.
Methods—Dysmobility was defined as three or more of the following: high body fat, 
osteoporosis, low muscle mass, low muscle strength, slow gait speed, or falling risk. Body 
composition and bone density were assessed with dual energy x-ray absorptiometry. Gait speed 
was measured via a timed walk, muscle strength via isokinetic knee extension, and fall risk via 
self-reported balance problems in the past year. Hazards ratios (HR) for mortality were calculated 
with Cox proportional hazards models.
Results—Twenty-two percent of adults age 50+ years had dysmobility in 1999–2002. Mortality 
risk by dysmobility varied significantly by age (pinteraction=0.001). HRs for those aged 50–69 
years were 3.63 (95% CI 2.69, 4.90) and 2.59 (95% CI 1.82, 3.69), respectively, before and after 
adjusting for all confounders, compared with 1.46 (95% CI 1.07, 1.99) and 1.23 (95% CI 0.89, 
1.69) for those aged 70+ years. The relationship was significant when examined by sex or race/
ethnicity within age group for most subgroups.
Conclusions—Dysmobility was associated with increased mortality risk in adults age 50 years 
and older, with risk being higher in those age 50–69 years than in those age 70+ years.
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Introduction
Interest in considering more than bone density when assessing skeletal health has grown 
considerably in the past decade. Recently Binkley et al [1] proposed to expand the adverse 
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musculoskeletal outcomes considered beyond fracture when evaluating older adults to 
include risk of disability, falls and mortality. They suggested evaluating a combination of 
conditions, which they named dysmobility syndrome, that share pathogenesis and may act 
together to increase risk of this wider range of adverse events. These authors noted that this 
combination is similar in concept to the metabolic syndrome that is now clinically used to 
assess cardiovascular risk [1]. They proposed a score-based approach to define dysmobility 
as having at least three of the following six conditions: osteoporosis, low muscle mass, low 
muscle strength, slow gait speed, history of falls and high body fat [1].
Binkley et al [1] noted that more work is needed to refine and evaluate the dysmobility 
concept, including assessing its link with adverse outcomes. The present study uses data 
from the National Health and Nutrition Examination Survey (NHANES) conducted in 1999–
2002 to examine the relationship between dysmobility and all-cause mortality in adults age 
50 years and older by age, sex, and race/ethnicity. The relationship between the individual 
conditions that compose dysmobility and all-cause mortality is also examined. Assessing 
these relationships may help to evaluate the utility of this new proposed syndrome, and also 
may provide insight on ways to further refine it.
Methods
Sample
The present study used data from the NHANES 1999–2002 because these survey cycles 
included measurements of the six conditions needed to define dysmobility as proposed by 
Binkley et al [1]. The NHANES is conducted by the National Center for Health Statistics 
(NCHS), Centers for Disease Control and Prevention, to assess the health and nutritional 
status of a large representative cross-sectional sample of the non-institutionalized, civilian 
US population. All procedures in NHANES 1999–2002 were approved by the NCHS 
Institutional Review Board, and written informed consent was obtained from all subjects [2].
Data were collected in NHANES 1999–2002 via household interviews and direct 
standardized physical examinations that were conducted in specially equipped mobile 
examination centers [2]. NHANES 1999–2002 was designed to provide reliable estimates 
for three race/ethnic groups: non-Hispanic whites (NHW), non-Hispanic blacks (NHB), and 
Mexican Americans (MA). Race and ethnicity were self-reported by the participants.
The analytic sample in this study consisted of persons ages 50 years and older at the time of 
their baseline interview. There were 2975 respondents age 50 years and older in the final 
analytic sample, which represents 60% of those who were interviewed, and 67% of those 
who were examined in NHANES 1999–2002. Descriptive characteristics and risk factors 
were compared between retained versus excluded respondents to assess potential 
nonresponse bias in study results. The excluded respondents were older, female, and had 
higher body fat and slower gait speed. They were also more likely to have died by 2011, and 
to be non-Hispanic black or other race. Finally, they were more likely to self-report fair or 
poor health, chronic conditions, previous fracture, and less activity than others of the same 
age or sex. Respondents and non-respondents did not differ in lumbar spine subregion bone 
mineral density (BMD), appendicular lean mass/height2, isokinetic knee extensor muscle 
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strength, smoking, or alcohol use, however. Analyses performed to assess the impact of 
potential nonresponse bias on results are described in more detail in the Statistical Analysis 
section.
Variables
Mortality—Vital status was determined through December 31, 2011 using the restricted 
access Linked Mortality File for NHANES 1999–2002. This file uses a probabilistic match 
between the eligible NHANES 1999–2002 sample and the National Death Index (NDI) to 
determine vital status [3].
Dysmobility conditions—Dysmobility was defined as having at least 3 of the following 
6 conditions: high body fat, osteoporosis, low muscle mass, low muscle strength, slow gait 
speed, and risk of falling. The measurements used to define each condition are described in 
detail below. Cutoffs for each condition are summarized in Table 1. The same methods and 
cutoffs as those used by Binkley et al [1] were applied in the present study for high body fat, 
low muscle mass and slow gait. However, different cutoffs for low muscle strength, 
osteoporosis and falling risk were used because different measurement methods were used 
in NHANES 1999–2002.
Total body DXA scans: Body fat, lean mass and bone density were measured using total 
body DXA scans. Total body scans were performed with Hologic QDR 4500A fan-beam 
densitometers (Hologic, Inc., Bedford, Massachusetts) using DOS software version 
8.26:a3*. Scanning was done in the fast mode. Details of the DXA examination protocol 
have been published elsewhere[4]. Each scan was reviewed and analyzed by the Department 
of Radiology of the University of California, San Francisco. Hologic Discovery software 
version 12.1 was used to analyze all total body scans.
Osteoporosis status was based on BMD from the lumbar spine subregion of the total body 
DXA scan because dedicated femur and lumbar spine scans were not performed in 
NHANES 1999–2002. Previous research indicates that BMD from the lumbar spine 
subregion of a total body scan correlates closely with BMD from a dedicated anterior-
posterior (AP) lumbar spine scan and results in similar estimates of osteoporosis prevalence 
and similar odds ratios for predicting fracture [7]. The diagnostic criteria for osteoporosis 
from the World Health Organization (WHO) were used to define lumbar spine osteoporosis. 
Specifically, respondents were defined as having osteoporosis if their lumbar spine BMD 
value fell more than −2.5 SD’s below the mean BMD of a young reference group [8]. The 
young reference group consisted of 30 year-old white females from the Hologic lumbar 
spine reference database, in accordance with recent recommendations from the International 
Society for Clinical Densitometry (ISCD) [9]. Reference values for the AP spine were used 
because reference data for the lumbar spine subregion from total body scans have not been 
published by the DXA manufacturer. Preliminary analyses showed that application of the 
Hologic AP thresholds to the lumbar spine subregion data from NHANES 1999–2002 
resulted in a similar prevalence of osteoporosis among adults age 50 years and older (6.3%) 
as that seen in this age group when based on dedicated AP spine scans from NHANES 
2005–2008 (6%) [10].
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Timed walk: A 20-foot (6.15 meter) timed walk performed at the respondent’s usual pace 
was used to assess gait speed [11]. Walk time was measured with a stop watch from the time 
the examinee’s foot first touched the floor across the start line until their foot touched the 
floor across the finish line. Respondents who needed the assistance of another person to 
walk were excluded from testing, but respondents who needed to use a walking device such 
as a walker or cane were permitted to use them during the test. Slow gait was defined as gait 
speed < 1.0 meters/second (Table 1).
Isokinetic knee extensor muscle strength: A Kinetic Communicator isokinetic 
dynamometer (Kin Com MP, Chattanooga Group, Inc., Chattanooga, TN) was used to 
evaluate knee extensor strength of the right quadriceps [11, 12]. Respondents were excluded 
from the muscle strength test if they had a recent history of myocardial infarction or chest or 
abdominal surgery, any history of aneurysm/stroke or current severe right knee pain, right 
knee or hip replacement, or severe neck or back pain. Peak force (PF, in Newton/meters 
(Nm)) of the quadriceps was measured at one speed (60 degrees/second). Only concentric 
movements were tested due to safety concerns. Each respondent was asked to perform three 
practice trials for warm-up and three trials for maximal voluntary effort. Peak force was 
defined as the highest value obtained from the maximum effort trials for those who 
completed at least 5 trials (approximately 98% of respondents). If four or fewer trials were 
completed, the highest PF from the completed trials was selected. Peak torque (PT) was 
calculated as: (PF x mechanical arm length in cm)/100. The mechanical arm length was 
defined as the distance from ankle to knee joint. Gravity corrections to torque were based on 
a measured leg weight at 2.62 radians (rad) (150 degrees; 3.14 rads being equivalent to a 
straight leg position).
Criteria to define low muscle strength on the basis of isokinetic knee extensor muscle 
strength have not been included in consensus definitions of sarcopenia published to date 
[13–15]. In the absence of such criteria, the present study used two approaches to define 
thresholds for low muscle strength. First, a healthy reference group of respondents age 50–
59 years from NHANES 1999–2002 was created by excluding individuals in that age range 
who suffered from any of the six conditions used to define dysmobility. Sex-specific 
thresholds for low muscle strength were defined as the peak torque value that fell more than 
2 SDs below the sex-specific mean peak torque of this healthy 50–59 year old reference 
group (Table 1). The mean minus 2 SD’s of this middle-aged reference group was used to be 
consistent with the ISCD definition of bone density that is below the expected range for age 
[9]. The second approach used sex-specific means and SDs from a sample of 28 healthy, 20–
29 year old Danish men and women [16]. The sex-specific thresholds to define low muscle 
strength using these Danish data (< 118.25 Nm for men and < 67.25 Nm for women) were 
defined as the peak torque value that fell more than 2.5 SDs below the sex-specific mean 
peak torque of this healthy 20–29 year-old Danish reference group. The mean minus 2.5 
SD’s of these young adults was used to be consistent with the WHO definition of 
osteoporosis [8]. Preliminary analyses indicated that the risk of mortality by dysmobility 
status was similar regardless of the thresholds used to define low muscle strength, so results 
presented below are based on thresholds derived from the 50–59 year old healthy reference 
group from NHANES 1999–2002.
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Balance problems: Risk of falling was defined as having problems with balance based on a 
single questionnaire item that asked respondents if they had dizziness, difficulties with 
balance, or difficulties with falling during the past 12 months. Those who responded “yes” 
were defined as having balance problems.
Confounding variables—Selected variables were evaluated for inclusion as possible 
confounders in multivariate models of mortality risk by dysmobility status. These were 
limited to variables that were not already encompassed by the dysmobility conditions, and 
included the following:
Smoking and alcohol intake: Cigarette use was categorized as ever smoked versus never 
smoked based on responses to questionnaire item asking “Have you ever smoked at least 
100 cigarettes in your lifetime?” Alcohol users were defined as respondents who self-
reported that they usually consumed three or more drinks per day when they drank alcohol.
Self-reported health status, physical activity and chronic conditions: Respondents were 
asked to rate their general health status as poor, fair, good, very good or excellent. 
Respondents were also asked to rate their current physical activity level as more active, less 
active, or about the same when compared to others of their same age and sex. Respondents 
who self-reported that a doctor had ever told them that they had angina, arthritis, cancer, 
chronic bronchitis, congestive heart failure, coronary heart disease, diabetes, emphysema, 
heart attack, any liver condition, stroke, or thyroid disease were considered to have chronic 
conditions.
Statistical analysis
All analyses were performed using SAS 9.3 (SAS Institute, Cary NC) and SUDAAN 
software [17] for analysis of data from complex survey samples. Descriptive characteristics 
and risk factors at baseline were compared by dysmobility status and mortality status using 
linear regression models and chi-square analyses. Risk factors that were significantly related 
to dysmobility or to mortality were used in subsequent multivariable models.
Risk of all-cause mortality by dysmobility status was analyzed using Cox proportional 
hazards models in order to control for all risk factors simultaneously and to account for 
unequal length of follow-up. Length of follow-up was calculated as the time from date of 
examination to date of death for decedents or end of follow-up on December 31, 2011 for 
non-decedents. A test of the proportional hazard assumption indicated no significant trend in 
hazards ratio (HR) with time (p=0.80), which suggests the assumption was not violated. Cox 
models were also used to obtain the HR for the individual conditions used to define 
dysmobility when tested in separate models, as well as in a single model to assess the 
contribution of each condition after adjusting for the other five conditions.
Secondary analyses were performed to assess the impact of possible nonresponse bias on 
results given the differences in several important characteristics related to health status 
described earlier between survey respondents and non-respondents in the analytic sample. 
Specifically, PROC WTADJUST was used to adjust the original sample weights using an 
approach described by Mirel et al [18]. Differences in results based on the adjusted weights 
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versus original sample weights were minor: estimates of dysmobility prevalence by 
demographic characteristics differed by 0–1.6 percentage units and estimates of HR for 
mortality by dysmobility differed by 0.03 units. As a result, all estimates presented are based 
on the original sample weights for the survey.
Secondary analyses were also performed to assess the influence of respondents with pre-
existing illness on mortality risk by comparing the results from the main analyses with those 
performed after excluding respondents with ≤ 2 years of follow-up after baseline.
Finally, secondary analyses were performed to assess the impact of using different 
thresholds for selected dysmobility conditions when assessing the risk of mortality by 
dysmobility status. Specifically, recent thresholds for gait speed and muscle mass proposed 
by the Foundation of the National Institutes of Health (FNIH) [15] were used in place of the 
thresholds for these two conditions shown in Table 1. The HR for mortality by dysmobility 
using the new cutoffs was compared with the HR for mortality by dysmobility obtained in 
the main analysis. In addition, Harrell’s R2 was calculated to compare the ability of the two 
models to predict mortality [19]. Harrell’s R2 is an estimate of the proportion of explained 
variance, and is calculated as: R2H = (log LR − log LU)/log LR, where log LR is the log-
likelihood ratio statistic for the Cox model without covariates and log LU is the log-
likelihood ratio statistics for the Cox model with covariates [19].
Results
Approximately 22 percent of adults age 50 years and older had dysmobility at baseline in 
1999–2002 (Table 2). The prevalence of dysmobility was significantly higher among 
respondents age 70 years and older at baseline than in those age 50–69 years. Respondents 
ages 70 years and older were also more likely to suffer from a greater concurrent number of 
the individual conditions that compose dysmobility than respondents ages 50–69 years 
(figure 1). In addition to being significantly related to age, dysmobility at baseline was also 
significantly related to sex (women > men) and to race or ethnicity (Mexican Americans and 
persons of other races > non-Hispanic whites or non-Hispanic blacks) (Table 2).
Respondents were followed for an average of 9.9 years after baseline. Twenty one percent of 
adults age 50 years and older at baseline were deceased by 2011 (Table 2). Mortality was 
significantly higher in the older age group compared to the younger group, and was also 
higher in non-Hispanic whites and non-Hispanic blacks than in Mexican Americans or other 
races (Table 2). Mortality also differed significantly by dysmobility status at baseline: 45% 
of respondents with dysmobility at baseline died by 2011, compared to 15% of respondents 
without dysmobility (p < 0.001).
Potential confounding health or lifestyle variables that were significantly related to both 
dysmobility and mortality included physical activity, self-reported health status, and self-
reported diagnosis of chronic conditions at baseline (Table 2). Those with dysmobility at 
baseline or who were deceased by 2011 were more likely to report less physical activity, 
being in fair or poor health, and having chronic conditions than those without dysmobility at 
baseline or who were alive in 2011. As a result, these three variables were included in 
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subsequent multivariate analyses. Two additional variables were related to either 
dysmobility or mortality, so were also included in subsequent multivariate analyses. 
Specifically, smoking status was significantly related to mortality status but not to 
dysmobility, while alcohol consumption was related to dysmobility but not mortality.
Table 3 summarizes risk of mortality by dysmobility status using the base model (adjusted 
for demographic variables) and full multivariate model (adjusted for significant health and 
lifestyle variables as well as demographic variables). These analyses were stratified by age 
because preliminary analyses revealed that a significant age X dysmobility status interaction 
existed for risk of mortality. Although mortality risk was significantly higher in those with 
dysmobility compared to those without dysmobility in both age groups after adjusting for 
demographic variables, the HR was roughly 2.5 times higher in those age 50–69 years 
(HR=3.63) than in those age 70 years and older (HR=1.46). The base model HR was also 
significantly elevated when examined by the other demographic characteristics in all groups 
except Mexican Americans among 50–69 year olds, but among those age 70 years and older, 
the base model HR was significant only for men and non-Hispanic whites. Adjusting for 
lifestyle and health-related variables in the full model attenuated the HR somewhat among 
50–69 year olds, but risk remained significantly elevated in all groups except Mexican 
Americans. In contrast, after adjusting for the additional variables in the 70+ year group, 
only the HR for men remained significantly elevated.
Results of the secondary analyses to assess the impact of pre-existing disease on results by 
limiting respondents to those with more than 2 years of follow-up indicated little effect of 
these conditions on conclusions. Specifically, the base model HR before and after excluding 
those with ≤ 2 years of follow up were almost identical in both age groups (HR=3.63 and 
3.65, respectively, for age 50–69 years; HR=1.46 and 1.40, respectively, for age 70+ years). 
Comparable results for the full model HR were also observed (HR=2.59 and 2.71, 
respectively, for age 50–69 years; HR=1.23 and 1.19, respectively, for age 70+ years).
HR adjusted for demographic variables by number of dysmobility conditions are shown by 
age group in Figure 2. There was a significant linear trend in the HR in both age groups 
(p<0.0001). Among 50–69 year olds, the HRs were statistically significant for those with 3 
or 4–6 conditions, but not for those with 1 or 2 conditions (figure 2A). Among those 70 and 
older, the HR for those with 4–6 conditions was significant, whereas the HR for fewer 
conditions was not (figure 2B). Of note, the lower limit of the 95% CI for the HR in those 70 
and older with 3 conditions just overlapped 1.00 (HR=2.16, 95% CI 0.98-XX). It is also 
important to note that several of the HR’s in both age groups had wide CI’s, possibly due to 
the low number of deaths in some of the categories.
Estimates of the prevalence of the individual conditions that compose dysmobility by age 
group are shown in Table 4. High body fat was very common in both age groups, affecting 
57% and 60% of the younger and older age groups, respectively. The other five conditions 
were 1.6–5 times more common in the older age group (in whom prevalence estimates 
ranged from 10–62%), than in the younger age group (in whom prevalence estimates ranged 
from 5–28%). Among the younger respondents, high body fat was most the common 
condition, followed by slow gait speed and balance problems in the past year. In the older 
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group, slow gait was the most common condition, followed by high body fat and low muscle 
strength.
Table 4 also provides two set of HR for these conditions after adjusting for age, sex, and 
race or ethnicity. The first set of HR pertains to each condition when tested in separate Cox 
models, while the second set of HR pertains to each condition when tested together in a 
single Cox model. When tested separately, differences in the relationship between these 
conditions and mortality risk by age are evident. For example, among 50–69 year olds, each 
condition was significantly associated with increased mortality risk when tested separately 
except lumbar spine osteoporosis. In contrast, among those age 70 years and older, high 
body fat, lumbar spine osteoporosis and low muscle mass were not significantly associated 
with increased mortality risk when tested separately, and the HR point estimate for high 
body fat suggested a protective effect. Deleting high fat from the dysmobility definition in 
this age group increased the HR for dysmobility to 1.80 (95% CI 1.44–2.26), but it remained 
significantly lower than the HR among 50–69 year olds.
Age differences were also evident when each condition was tested in a single model that 
included the other five conditions in addition to the demographic variables (Table 4). 
Balance problems, low muscle strength, and high percent body fat remained significantly 
associated with mortality risk among 50–69 year olds when all six conditions were tested 
together, while balance problems and slow gait speed remained significantly associated with 
mortality risk among those age 70 years and older.
Results of secondary analyses performed to assess the impact of using FNIH thresholds for 
gait speed and low muscle mass instead of the cutpoints used in the main analyses for these 
conditions revealed little impact on HR for mortality by dysmobility status. Specifically, 
after adjusting for age, sex, and race or ethnicity, the HR for mortality by dysmobility status 
in the total sample was 1.94 (95% confidence interval (CI) 1.45, 2.59) when the original 
cutpoints were used to define dysmobility, compared to 2.08 (95% CI 1.65, 2.64) when the 
FNIH cutpoints were used. Harrell’s R2 was 0.029 for both approaches.
Discussion
Dysmobility syndrome was significantly associated with increased mortality risk in adults 
age 50 and older from NHANES 1999–2002 when examined by age, sex, and race/ethnicity. 
Dysmobility was also a relatively common condition, affecting roughly 22% of adults age 
50 years and older in 1999–2002. This relatively common prevalence coupled with its link 
to increased mortality risk lend support to the proposal from Binkley et al [1] to use this 
constellation of musculoskeletal and mobility conditions to identify older adults at risk of 
adverse outcomes.
Although dysmobility was significantly related to mortality risk in both age groups 
examined in the present study, the magnitude of risk differed significantly by age. 
Specifically, the HR for mortality was roughly 2.5 times greater in 50–59-year-old 
respondents with dysmobility (HR=3.63) than in respondents age 70 years and older with 
this condition (HR=1.46) (p for age X dysmobility interaction = 0.001). This pattern 
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occurred even though older respondents were more likely to have more than three individual 
dysmobility conditions concurrently than younger respondents. The pattern of higher HR 
point estimates for dysmobility in the younger age group seen in the total sample was also 
apparent when the HR for dysmobility was examined separately by sex and race/ethnicity. 
Finally, the same age pattern emerged for HR associated with most of the individual 
conditions that compose dysmobility when they were examined in separate models.
Attenuation of mortality risk with age has been seen for other risk factors, such as body fat 
or body mass index and smoking [20, 21]. One possible explanation for this phenomenon is 
the steep rise of absolute mortality above age 70 in all respondents, which acts to attenuate 
the magnitude of relative effect estimates that compare mortality in those with a risk factor 
to those without it. Another explanation might be presence of pre-existing illness or disease 
that was not captured by adjusting for confounders in present study. Excluding respondents 
with ≤ 2 years of follow-up did not alter the HR for dysmobility, which suggests pre-
existing illness did not play a major role in the present study However, there is some 
disagreement as to whether deleting individuals with short amounts of follow-up time can 
adequately decrease confounding due to pre-existing disease [22, 23].
Another possible explanation for the age pattern in HR for mortality by dysmobility status 
might be related to age differences in the occurrence of the individual conditions that were 
used to define dysmobility. For example, there was some variability in the prevalence of the 
individual conditions by age, which suggests that dysmobility status might be based on 
presence of a somewhat different set of conditions in the two age groups. The two most 
prevalent conditions in both age groups were high body fat and slow gait speed. However, 
the third most common condition in the younger age group was balance problems, compared 
to low muscle strength in the older age group.
Differences in mortality risk associated with the individual conditions by age could also play 
a role in the observed age patterns. When examined separately, the six individual conditions 
generally had HR point estimates that suggested an increased risk of mortality in the 
younger age group, although not all the HR were statistically significant. In contrast, the HR 
point estimate for high body fat in the older age group, while not statistically significant, 
suggested that body fat might be protective against mortality risk in that age range. Some, 
but not all, studies have also found mortality risk to be unrelated to obesity or to be 
attenuated among those in the oldest age groups [21, 24]. Finally, a somewhat different set 
of conditions remained significant predictors of mortality in the two age groups when 
considered together in a single model. Specifically, balance problems remained a significant 
predictor of mortality after adjusting for the other five dysmobility conditions in both age 
groups. However, high body fat and low muscle strength also remained significant 
predictors in the younger age group, while slow gait speed was the only other predictor that 
remained significant in the older age group.
Mortality risk was significantly related to the number of dysmobility conditions in a linear 
fashion in both age groups. The increased risk in those with at least 3 conditions was 
statistically significant in 50–69 year-olds and just missed significance in those aged 70 and 
older, which suggests that use of 3 conditions to define dysmobility syndrome is reasonable. 
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However, power was not optimal to address this issue in the present study, as indicated by 
the wide 95% CI’s for several of the HRs.
The present study used the same measurement methods and thresholds to define the 
individual dysmobility conditions as Binkley et al [1] whenever possible. However the 
definition of osteoporosis, falling risk, and muscle strength differed because NHANES 
1999–2002 employed different methods to measure the relevant variables for these 
conditions. Specifically, osteoporosis was based on lumbar spine BMD only, and BMD data 
from the lumbar spine subregion from total body DXA scans were used instead of BMD 
from a dedicated AP spine. Previous research found that lumbar spine BMD measured by 
these two approaches were highly correlated, produced similar estimates of osteoporosis 
prevalence and had a similar association with fracture [7]. However, some misclassification 
of osteoporosis status of individual respondent was observed [7]. In addition, total body 
subregion measurements are not as accurate or precise as those from dedicated scans [7]. 
Finally, history of balance problems in past year was used to assess falling risk rather than 
number of falls, and isokinetic knee extensor muscle strength was used in place of grip 
strength to estimate muscle strength
Binkley et al [1] noted that their proposed cutpoints to define abnormality for the six 
conditions, while based on expert consensus to the extent possible, might require revision as 
more evaluation of the dysmobility concept occurs. Results from the present study in which 
two different sets of thresholds were evaluated when defining some of the individual 
conditions may provide some insight into this possibility. Specifically, two sets of thresholds 
to define low muscle strength were tested because thresholds to define low muscle strength 
based on isokinetic knee extensor muscle strength have not been provided in consensus 
statements [13–15]. In addition, new thresholds for gait speed and muscle mass developed 
by the FNIH that were released subsequent to the study by Binkley et al [1] were tested in 
the present study. In the present study, the HR’s for dysmobility were similar regardless of 
the thresholds used to define these three conditions. Whether this lack of impact extends to 
the other conditions or to use of different thresholds for more than three of the dysmobility 
conditions is not clear, however. It is also not clear whether HR for other adverse outcomes 
like fracture would be unaffected by changes in thresholds.
Study limitations include potential misclassification of osteoporosis status because it was 
based on lumbar spine BMD only. This misclassification can occur when either AP or total 
body DXA scans are used due to presence of artifacts such as aortic calcification or 
osteophytes that may falsely elevate these BMD measurements. In addition, exclusions for 
missing data resulted in creation of an analytic sample with respondents who differed from 
excluded respondents in a number of ways that could affect the generalizability of results. 
Specifically, excluded respondents were more likely to be older, have several indications of 
poor health and to have high body fat and slow gait speed, which are two of the conditions 
used to define dysmobility. Secondary analyses were performed to address this potential 
non-response bias by adjust the sampling weights via re-weighting. Results based on the 
adjusted sampling weights were similar to those obtained when the original sampling 
weights were used, which suggests that the exclusions from the analytic sample did not 
introduce serious biases. However, these analyses cannot completely rule out nonresponse 
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bias because the sample size was not large enough to permit reweighting by all the 
characteristics that varied between respondents and nonrespondents.
In conclusion, mortality risk was significantly increased in respondents with dysmobility in 
this sample derived from a nationally representative survey. The relationship was stronger in 
those age 50–69 years than in those age 70 years and older, which supports the utility of 
evaluating persons in this younger age range for dysmobility despite their lower prevalence 
of the condition. The present study supports the predictive utility of dysmobility for 
mortality, but additional work is needed to evaluate its relationship with other adverse 
outcomes like mobility disability, falls and fractures.
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HR for mortality by number of dysmobility conditions and age group
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High body fat Framingham [25] Percent body fat > 30 Percent body fat >40
Low muscle mass
European Working Group on 
Sarcopenia in Older People [26] [13] ALM/ht2 < 7.26 ALM/ht2< 5.45
Slow gait
International Working Group on 
Sarcopenia [14] < 1.0 meters/sec < 1.0 meters/sec
Low strength
Peak knee extensor torque < − 2 SD’s 
below mean of NHANES 50–59 
healthy reference group*
Peak knee extensor torque <104.4 
Nm
Peak knee extensor torque <62.6 
Nm
Osteoporosis
International Society for Clinical 
Densitometry 2013 Adult Position 
Paper [9]
< − 2.5 SD below mean lumbar 
spine BMD of 30 year old white 
women in DXA manufacturer 
reference database
< − 2.5 SD below mean lumbar 
spine BMD of 30 year old white 




falls) in past year Not applicable Yes for any problem Yes for any problem
*
do not have any of the individual conditions composing dysmobility syndrome
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